What Happened?
Watertown, MA-based Tarveda Therapeutics Appointed Mark Bilodeau as Senior Vice President
About the Company
Tarveda Therapeutics is a clinical stage biopharmaceutical company that takes a novel approach to cancer treatment by creating proprietary Pentarins, which are potent and selective, miniaturized conjugates uniquely designed to drive efficacy through deep and rapid penetration into solid tumors resulting in sustained payload accumulation and cancer cell death. Through our Pentarin platform, we are developing therapeutics to address the limitations of current cancer therapies in solid tumors.
About the Person
Mark Bilodeau is Senior Vice President at Tarveda Therapeutics. Previously, Mark held various senior HR leadership roles in the industry.
Info Source
News
Short Profile